Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide
Prescription상품명: Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide
About This Medication
DESCRIPTION Brompheniramine Maleate, Pseudoephedrine Hydrochloride and Dextromethorphan Hydrobromide Oral Syrup is a clear, light pink syrup with a butterscotch flavor. Each 5 mL (1 teaspoonful) contains: Brompheniramine Maleate, USP ................. 2 mg Pseudoephedrine Hydrochloride, USP ........ 30 mg Dextromethorphan Hydrobromide, USP ...... 10 mg Alcohol 0.95% v/v In a palatable, aromatic vehicle. Inactive Ingredients: alcohol, artificial butterscotch flavor, citric acid anhydrous, glycerin, methylparaben, propylene glycol, purified water, sodium benzoate, sodium citrate, sucrose, and FD&C Red No. 40. It may contain 10% citric acid solution or 10% sodium citrate solution for pH adjustment. The pH range is between 3.0 and 6.0. Antihistamine/Nasal Decongestant/Antitussive syrup for oral administration. Chemical Structure 1 Chemical Structure 2 Chemical Structure 3
유효 성분
| 성분 | 함량 |
|---|---|
| Brompheniramine Maleate | - |
| Dextromethorphan Hydrobromide | - |
| Pseudoephedrine Hydrochloride | - |
적응증 및 용법
용량 및 투여 방법
Side Effects Overview
경고 및 주의 사항
WARNINGS Especially in infants and small children, antihistamines in overdosage may cause hallucinations, convulsions, and death. Antihistamines may diminish mental alertness. In the young child, they may produce excitation.
금기
CONTRAINDICATIONS Hypersensitivity to any of the ingredients. Do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. Do not use dextromethorphan in patients receiving monoamine oxidase (MAOI) inhibitors ( see PRECAUTIONS – Drug Interactions ). Antihistamines should not be used to treat lower respiratory tract conditions including asthma.
Frequently Asked Questions
INDICATIONS AND USAGE For relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold.
DOSAGE AND ADMINISTRATION Adults and pediatric patients 12 years of age and over: 10 mL (2 teaspoonfuls) every 4 hours. Children 6 to under 12 years of age: 5 mL (1 teaspoonful) every 4 hours. Children 2 to under 6 years of age: 2.5 mL (½ teaspoonful) every 4 hours. Infants 6 months to under 2 years of age: Dosage to be established by a physician. Do not exceed 6 doses during a 24-hour period.
WARNINGS Especially in infants and small children, antihistamines in overdosage may cause hallucinations, convulsions, and death. Antihistamines may diminish mental alertness. In the young child, they may produce excitation.
CONTRAINDICATIONS Hypersensitivity to any of the ingredients. Do not use in the newborn, in premature infants, in nursing mothers, or in patients with severe hypertension or severe coronary artery disease. Do not use dextromethorphan in patients receiving monoamine oxidase (MAOI) inhibitors ( see PRECAUTIONS – Drug Interactions ). Antihistamines should not be used to treat lower respiratory tract conditions including asthma.
Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Liquid/Solution Products
Browse all Liquid/Solution products →References & Data Sources
- • DailyMed — Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide drug label (National Library of Medicine)
- • openFDA — Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 1357010 (NLM Normalized Drug Names)
- • NDC Directory — Brompheniramine Maleate, Pseudoephedrine Hydrochloride And Dextromethorphan Hydrobromide (FDA National Drug Code)
의료 면책 조항
이 페이지의 정보는 교육 목적으로만 제공되며, 전문적인 의학적 조언, 진단 또는 치료를 대체하는 용도로 사용해서는 안 됩니다.
의학적 상태나 의약품에 관한 질문이 있으시면 반드시 의사 또는 자격을 갖춘 의료 전문가에게 조언을 구하시기 바랍니다.
데이터 출처: DailyMed (NLM), openFDA, MFDS